GLF
TDOC icon

Groupe la Francaise’s Teladoc Health TDOC Stock Holding History

Groupe la Francaise’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68
Closed -$475 – 754
2025
Q3 		$475 Buy
+68
New +$531 ﹤0.01% 753

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Groupe la Francaise's TDOC Position: Q4 2025 in Review

Groupe la Francaise sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 68 shares — an estimated $475 sold.

Groupe la Francaise first reported a position in TDOC in Q3 2025 and held it in 1 quarter. The position peaked at $475 in Q3 2025. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Groupe la Francaise reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 68 Teladoc Health shares in Q4 2025, an estimated $475.
  • Groupe la Francaise first reported a position in Teladoc Health in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's Teladoc Health position peaked at $475 in Q3 2025.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.